Which funds bought or sold RGEN in Q3 2026?
Repligen Corp. 4 funds bought, 2 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was +$931M.
Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)
Top 10 each side. NEW = opened a position, OUT = sold the whole position.
Bought (4)
| Fund | Change | Est. $ | Now |
|---|---|---|---|
| Fidelity Asset manager | Added+121% | +$774M | $1.4B |
| Invesco Asset manager | Added+53.8% | +$144M | $410M |
| Capital Research Asset manager | New | +$138M | $138M |
| Viking Hedge fund | New | +$102M | $102M |
Sold (2)
Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.